Back

Prognostic utility of urinary biomarkers following decongestive therapy in acute decompensated heart failure

28 August 2018 (08:57 - 09:06)
Organised by:
Congress Presentation Part of: "Biomarkers reloaded": Diagnosis and prognosis of acute heart failure Biomarkers ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Takashi Kuragaichi

Hyogo Prefectural Amagasaki Hospital, Amagasaki (Japan)

8 More presentations in this session

Presentation thumbnail
Circulating molecular forms of ANP and BNP in human acute decompensated Heart Failure: evidence for a relative ANP deficiency state
Mr S. Reginauld (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Biomarker profile of patients with recovery of left ventricular systolic function following acute cardiac decompensation
Ms J. Albert (Wuerzburg, DE)
Abstract
Presentation thumbnail
Prognostic value of serum cholinesterase in patients with acute decompensated heart failure: a prospective comparative study with other nutritional indexes
Doctor M. Seo (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Differential urine proteomic signature in early phase of renal insufficiency in patients with acute heart failure
Doctor T. Padro (Barcelona, ES)
Abstract
Presentation thumbnail
Combination of presepsin, soluble CD14 subtype, and B-type natriuretic peptide predicts six-month mortality in patients hospitalized for worsening heart failure
Professor J. Ishii (Nagoya, JP)
Abstract Slides Video

Access the full session

Session thumbnail
"Biomarkers reloaded": Diagnosis and prognosis of acute heart failure

The Event

Event poster

ESC Congress 2018

28 August 2018 08:57 CET
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on current state of the diagnosis of heart failure
thumbnail
Congress Presentation
The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure
thumbnail
Congress Session
From genetic signatures to clinical implications

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources